@FiercePharma: Watson nabs authorized-generic deal with J&J. Article | Follow @FiercePharma
> The European Medicines Agency has appointed its administrative head, Andreas Pott, as acting executive director from Jan. 1, following a series of delays in recruiting a new permanent leader. Report
> The Sanofi-Aventis site at Alnwick, U.K., has been bought by American firm Covance, with the majority of the 140 staff transferring to the new owner. Article
> At a time when the FDA is increasingly criticized for its oversight of foreign drug-making plants, the chief of its recently created International Compliance Branch has departed. Item
> Valeant Pharmaceuticals (VRX.TO) posted a quarterly loss, hurt by increased expenses, in its first quarter after being bought by Biovail and set a special dividend as well as a $1.5 billion buyback. Report
> Amylin Pharmaceuticals (AMLN) Chief Executive Daniel Bradbury said the drugmaker can withstand the recent setback it suffered when U.S. regulators declined to approve its proposed diabetes drug Bydureon. News
> Watson Pharmaceuticals (WPI.N) posted a huge drop in net income due to a legal settlement charge but reported profit excluding items and revenue slightly ahead of Wall Street targets. Story
> Par Pharmaceutical (PRX.N) posted a better-than-expected quarterly profit, helped by robust sequential growth of its generic drugs and a strong start to its omeprazole sodium bicarbonate capsules. Article
@FierceBiotech: Biogen restructuring claims 650 jobs. Article | Follow @FierceBiotech
> Report: Acceleron cuts 40% of staff. Story
> NASDAQ gives Cell Therapeutics another warning. Item
> Newron, Merck Parkinson's drug misses goal. Article
> CRO Charles River cuts 300 more jobs. Item
Vaccines News
> Study: Support of mandatory HPV vaccine declines after negative news coverage. Item
> GlobeImmune HCV vax shows promise in trial. Story
> Sanofi dengue vax enters PhIII. Article
> The 26 vaccine-preventable diseases. Report
> Report: Higher income parents increasingly forgoing kids' vaccinations. News
Manufacturing News
> Safety advocates say FDA guidance not enough. Article
> DARPA efforts tweak tobacco-based vax making. Story
> ERP provides ops boosts at AHN, BioVectra. Item
> Plastic pallet makers report for duty. Article
> Novartis journeys to Mecca for Saudi vax effort. Report
> FDA reminds, guides on fighting musty odor. Item
And finally ... A drug approved to help staunch bleeding in people with hemophilia raises the risk of heart attacks and stroke when it's used to stop life-threatening bleeding due to other conditions, such as trauma or surgery, a new study finds. Report